Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Amortization of Deferred Charges (2020 - 2025)

Historic Amortization of Deferred Charges for Marimed (MRMD) over the last 5 years, with Q3 2025 value amounting to $18000.0.

  • Marimed's Amortization of Deferred Charges fell 7804.88% to $18000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7000.0, marking a year-over-year decrease of 9675.93%. This contributed to the annual value of $104000.0 for FY2024, which is 7158.47% down from last year.
  • According to the latest figures from Q3 2025, Marimed's Amortization of Deferred Charges is $18000.0, which was down 7804.88% from $6000.0 recorded in Q2 2025.
  • In the past 5 years, Marimed's Amortization of Deferred Charges registered a high of $181000.0 during Q2 2023, and its lowest value of -$47000.0 during Q4 2024.
  • In the last 4 years, Marimed's Amortization of Deferred Charges had a median value of $40500.0 in 2024 and averaged $58376.8.
  • Within the past 5 years, the most significant YoY rise in Marimed's Amortization of Deferred Charges was 400000.0% (2024), while the steepest drop was 17230.77% (2024).
  • Over the past 4 years, Marimed's Amortization of Deferred Charges (Quarter) stood at $176522.0 in 2021, then tumbled by 63.18% to $65000.0 in 2023, then tumbled by 172.31% to -$47000.0 in 2024, then surged by 138.3% to $18000.0 in 2025.
  • Its Amortization of Deferred Charges stands at $18000.0 for Q3 2025, versus $6000.0 for Q2 2025 and $30000.0 for Q1 2025.